COVID-19 and the nicotinic cholinergic system

The prevalence of smoking among hospitalised COVID-19 patients is low. COVID-19 manifestations could be linked to impairment of the cholinergic anti-inflammatory pathway. Nicotinic cholinergic agonists should be examined as potential therapeutic options. https://bit.ly/2zfUZ1S

Detalles Bibliográficos
Autores principales: Farsalinos, Konstantinos, Angelopoulou, Athina, Alexandris, Nikos, Poulas, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248130/
https://www.ncbi.nlm.nih.gov/pubmed/32444400
http://dx.doi.org/10.1183/13993003.01589-2020
_version_ 1783538302028087296
author Farsalinos, Konstantinos
Angelopoulou, Athina
Alexandris, Nikos
Poulas, Konstantinos
author_facet Farsalinos, Konstantinos
Angelopoulou, Athina
Alexandris, Nikos
Poulas, Konstantinos
author_sort Farsalinos, Konstantinos
collection PubMed
description The prevalence of smoking among hospitalised COVID-19 patients is low. COVID-19 manifestations could be linked to impairment of the cholinergic anti-inflammatory pathway. Nicotinic cholinergic agonists should be examined as potential therapeutic options. https://bit.ly/2zfUZ1S
format Online
Article
Text
id pubmed-7248130
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-72481302020-06-02 COVID-19 and the nicotinic cholinergic system Farsalinos, Konstantinos Angelopoulou, Athina Alexandris, Nikos Poulas, Konstantinos Eur Respir J Agora The prevalence of smoking among hospitalised COVID-19 patients is low. COVID-19 manifestations could be linked to impairment of the cholinergic anti-inflammatory pathway. Nicotinic cholinergic agonists should be examined as potential therapeutic options. https://bit.ly/2zfUZ1S European Respiratory Society 2020-07-16 /pmc/articles/PMC7248130/ /pubmed/32444400 http://dx.doi.org/10.1183/13993003.01589-2020 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Agora
Farsalinos, Konstantinos
Angelopoulou, Athina
Alexandris, Nikos
Poulas, Konstantinos
COVID-19 and the nicotinic cholinergic system
title COVID-19 and the nicotinic cholinergic system
title_full COVID-19 and the nicotinic cholinergic system
title_fullStr COVID-19 and the nicotinic cholinergic system
title_full_unstemmed COVID-19 and the nicotinic cholinergic system
title_short COVID-19 and the nicotinic cholinergic system
title_sort covid-19 and the nicotinic cholinergic system
topic Agora
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248130/
https://www.ncbi.nlm.nih.gov/pubmed/32444400
http://dx.doi.org/10.1183/13993003.01589-2020
work_keys_str_mv AT farsalinoskonstantinos covid19andthenicotiniccholinergicsystem
AT angelopoulouathina covid19andthenicotiniccholinergicsystem
AT alexandrisnikos covid19andthenicotiniccholinergicsystem
AT poulaskonstantinos covid19andthenicotiniccholinergicsystem

Ejemplares similares